Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls

• Walter Maetzler ,

  Contributed equally to this work with: Walter Maetzler, Anja Apel, Markus Langkamp

  * E-mail: Walter.maetzler@uni-tuebingen.de

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯
• Anja Apel ,

  Contributed equally to this work with: Walter Maetzler, Anja Apel, Markus Langkamp

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯
• Markus Langkamp ,

  Contributed equally to this work with: Walter Maetzler, Anja Apel, Markus Langkamp

  Affiliation Mediagnost, Reutlingen, Germany

  ⨯
• Christian Deuschle,

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯
• Sarah Selina Dilger,

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯
• Johannes Georg Stirnkorb,

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯
• Claudia Schulte,

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯
• Erwin Schleicher,

  Affiliation Department of Internal Medicine IV, University Hospital Tuebingen, Tuebingen, Germany

  ⨯
• Thomas Gasser,

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯
• Daniela Berg

  Affiliations Center of Neurology, Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany, DZNE, German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany

  ⨯